KNTE
Royal Bank of Canada’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14
| Closed | – | – | 7255 |
|
|
2024
Q1 | $0 | Buy |
14
+11
| +367% | – | ﹤0.01% | 7149 |
|
|
2023
Q4 | $0 | Sell |
3
-23
| -88% | – | ﹤0.01% | 7129 |
|
|
2023
Q3 | $0 | Sell |
26
-479
| -95% | – | ﹤0.01% | 7176 |
|
|
2023
Q2 | $2K | Sell |
505
-1,634
| -76% | -$6.47K | ﹤0.01% | 6470 |
|
|
2023
Q1 | $13K | Sell |
2,139
-3,136
| -59% | -$19.1K | ﹤0.01% | 5829 |
|
|
2022
Q4 | $32K | Buy |
5,275
+4,419
| +516% | +$26.8K | ﹤0.01% | 5644 |
|
|
2022
Q3 | $10K | Buy |
856
+192
| +29% | +$2.24K | ﹤0.01% | 5949 |
|
|
2022
Q2 | $8K | Sell |
664
-1,418
| -68% | -$17.1K | ﹤0.01% | 6022 |
|
|
2022
Q1 | $24K | Sell |
2,082
-3,504
| -63% | -$40.4K | ﹤0.01% | 6033 |
|
|
2021
Q4 | $100K | Buy |
5,586
+1,923
| +52% | +$34.4K | ﹤0.01% | 5415 |
|
|
2021
Q3 | $85K | Buy |
3,663
+1,651
| +82% | +$38.3K | ﹤0.01% | 5316 |
|
|
2021
Q2 | $48K | Buy |
2,012
+224
| +13% | +$5.34K | ﹤0.01% | 5584 |
|
|
2021
Q1 | $56K | Buy |
1,788
+1,288
| +258% | +$40.3K | ﹤0.01% | 5324 |
|
|
2020
Q4 | $20K | Buy |
+500
| New | +$20K | ﹤0.01% | 5524 |
|